Heat-Based Ablation Treatment for Lung Tumors in Lung Cancer Patients
Tests heat-based needle treatment to destroy lung cancer tumors in patients who cannot have surgery.
Plain-language title generated from the registry record
Registry title: Percutaneous Thermal Ablation in Lung Tumors
Key facts
- Where
- Asyut, EgyptSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with a lung tumor smaller than 5 cm (2 in), or cancer that spread to the lung. It also includes people with lung cancer and other illnesses who cannot have surgery.
- Sex
- All sexes can join.
- Disease stage
- Lung cancer smaller than 5 cm (2 in), or cancer that has spread (metastasis) to the lung. Stage II or higher cannot join.
- Earlier treatment
- People with lung cancer and multiple other illnesses who are unfit for surgery can join.
Main reasons for not taking part
- Lung cancer larger than 5 cm (2 in)
- Lung cancer stage II or more
- People who cannot tolerate CT-guided needle placement for thermal ablation
Read by machine on 12 November 2026.
Where in Egypt
- Faculty of medicineAsyut, EgyptContact: Abdulrahman F Ali, ResidentTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Assiut University
- Trial code
- NCT06891183
- Record updated
- 24 March 2025
- Original description
Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females. While surgery is the preferred treatment for stage 1 non-small cell lung cancer due to positive outcomes, it carries significant risks due to patient comorbidities. Non-invasive treatments like radio frequency ablation (RFA) and microwave ablation (MWA) are alternatives for those unable to undergo surgery. These techniques use energy to destroy tumor tissue with minimal invasiveness and can be guided by computed tomography to ensure accurate ablation.Read full original descriptionShow less
Percutaneous Thermal Ablation in Treatment of Lung Cancer
Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females. While surgery is the preferred treatment for stage 1 non-small cell lung cancer due to positive outcomes, it carries significant risks due to patient comorbidities. Non-invasive treatments like radio frequency ablation (RFA) and microwave ablation (MWA) are alternatives for those unable to undergo surgery. These techniques use energy to destroy tumor tissue with minimal invasiveness and can be guided by computed tomography to ensure accurate ablation.
Inclusion: lung cancer smaller than 5 cm; metastasis to the lung; patients with lung cancer and multiple comorbidities who are unfit for surgery.
Exclusion: lung cancer larger than 5 cm; lung cancer stage II or more; patients who cannot tolerate CT guided needle placement for thermal ablation of lung tumors.